BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 38511644)

  • 1. [Exploration of mechanism of total triterpenoids from fruits of Chaenomeles speciosa against senescent GES-1 cells induced by D-galactose based on Gln/GLS1/α-KG metabolic axis and mitochondrial apoptosis signaling pathway].
    He JY; Yang JX; Qin SY; Zheng JQ; Guo YR; Ma TX
    Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2230-2246. PubMed ID: 38812238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy.
    Zhang N; Ping W; Rao K; Zhang Z; Huang R; Zhu D; Li G; Ning S
    J Control Release; 2024 May; 371():204-215. PubMed ID: 38810704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NAMPT markedly enhances plasma-activated medium-induced cell death in human breast cancer MDA-MB-231 cells.
    Nagaya M; Hara H; Kamiya T; Adachi T
    Arch Biochem Biophys; 2019 Nov; 676():108155. PubMed ID: 31628926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
    Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
    Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma-activated medium-induced intracellular zinc liberation causes death of SH-SY5Y cells.
    Hara H; Taniguchi M; Kobayashi M; Kamiya T; Adachi T
    Arch Biochem Biophys; 2015 Oct; 584():51-60. PubMed ID: 26319292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in intracellular mobile zinc levels affect susceptibility to plasma-activated medium-induced cytotoxicity.
    Hara H; Sueyoshi S; Taniguchi M; Kamiya T; Adachi T
    Free Radic Res; 2017 Mar; 51(3):306-315. PubMed ID: 28325093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice.
    Boysen G; Jamshidi-Parsian A; Davis MA; Siegel ER; Simecka CM; Kore RA; Dings RPM; Griffin RJ
    Int J Radiat Biol; 2019 Apr; 95(4):436-442. PubMed ID: 30557074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glutamine metabolism increases sensitivity to plasma-activated medium-induced cytotoxicity.
    Tanaka S; Hayashi S; Otsuka T; Kamiya T; Ishikawa K; Hara H
    Free Radic Res; 2024 Mar; 58(3):170-179. PubMed ID: 38511644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular Mechanisms Underlying Cellular Responses to the Loading of Non-thermal Atmospheric Pressure Plasma-activated Solutions].
    Adachi T
    Yakugaku Zasshi; 2021; 141(10):1185-1194. PubMed ID: 34602515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Development of Small Molecule Glutaminase Inhibitors.
    Song M; Kim SH; Im CY; Hwang HJ
    Curr Top Med Chem; 2018; 18(6):432-443. PubMed ID: 29793408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and Mechanisms of Non-Thermal Plasma-Mediated ROS and Its Applications in Animal Husbandry and Biomedicine.
    Yang Y; Wang Y; Wei S; Wang X; Zhang J
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting GLS1 to cancer therapy through glutamine metabolism.
    Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y
    Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.